Prev：Development of a local drug delivery system for promoting the regeneration of infective bone defects: composite films with controlled properties.(KTA1020-3)
Next：Development of a monoclonal antibody against PRRSV glycoprotein 3 using an immuodominant peptide as immunogen(A21010-5)
